Indication :
- advanced ovarian carcinoma
- small cell and non small cell carcinoma of the lung
- squamous cell carcinoma of the head and neck
- advanced transitional cell carcinoma of the bladder
- significant responses have been observed when KEMOBOTIN® employed in the treatment of carcinoma of the cervix.
KEMOBOTIN® is frequently used in combination with other chemotherapeutic agent in various indications, such as with paclitaxel in first line therapy of ovarian carcinoma and non small cell lung cancer.
Compositions :
Each mL contain Carboplatin 10 mg
Storage Condition :
Store below 25°C, protect from direct sunlight. Do not freeze
